Wolverine Trading, LLC Seelos Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 15, 2023	BUY	$0.16 - $1.64 $2,784 - $28,536	17,400 New	17,400 $3,000
Q1 2023 May 15, 2023	BUY	$0.59 - $1.04 $9,381 - $16,536	15,900 Added 50.96%	47,100 $33,000
Q4 2022 Feb 14, 2023	SELL	$0.66 - $1.34 $6,732 - $13,668	-10,200 Reduced 24.64%	31,200 $21,000
Q3 2022 Nov 14, 2022	BUY	$0.65 - $1.41 $26,910 - $58,374	41,400 New	41,400 $44,000
Q1 2022 May 16, 2022	SELL	$0.84 - $1.71 $17,640 - $35,910	-21,000 Closed	0 $0

Q4 2021 Feb 14, 2022	BUY	$1.59 - $2.38 $33,390 - $49,980	21,000 New	21,000 $34,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $59.7M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.